[HTML][HTML] Role of p53 in breast cancer progression: An insight into p53 targeted therapy

C Marvalim, A Datta, SC Lee - Theranostics, 2023 - ncbi.nlm.nih.gov
The transcription factor p53 is an important regulator of a multitude of cellular processes. In
the presence of genotoxic stress, p53 is activated to facilitate DNA repair, cell cycle arrest …

Tumor microenvironment: a prospective target of natural alkaloids for cancer treatment

Y Luo, S Yin, J Lu, S Zhou, Y Shao, X Bao… - Cancer Cell …, 2021 - Springer
Malignant tumor has become one of the major diseases that seriously endangers human
health. Numerous studies have demonstrated that tumor microenvironment (TME) is closely …

Undescribed isoquinolines from Zanthoxylum nitidum and their antiproliferative effects against human cancer cell lines

F Qin, CY Wang, CG Wang, Y Chen, JJ Li, MS Li… - Phytochemistry, 2023 - Elsevier
Eleven previously undescribed alkaloids, including three pairs of enantiomers
nitidumalkaloids A–C, a pair of scalemic mixtures nitidumalkaloid D and three optically pure …

Metformin enhances the anti-cancer efficacy of sorafenib via suppressing MAPK/ERK/Stat3 axis in hepatocellular carcinoma

S Siddharth, P Kuppusamy, Q Wu… - International journal of …, 2022 - mdpi.com
Hepatocellular carcinoma (HCC) incidence, as well as related mortality, has been steadily
increasing in the USA and across the globe, partly due to the lack of effective therapeutic …

Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis

M Garg - Expert Reviews in Molecular Medicine, 2017 - cambridge.org
Cancer metastasis occurs through local invasion of circulating tumour cells (CTCs),
intravasation, transportation to distant sites, and their extravasation followed by colonisation …

[HTML][HTML] MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells

SZ Zheng, P Sun, JP Wang, Y Liu… - World journal of …, 2019 - ncbi.nlm.nih.gov
BACKGROUND Hepatocellular carcinoma (HCC) is the third leading cause of death from
malignant tumors worldwide. More than 50% of HCC cases occur in China. The prognosis …

[HTML][HTML] miR-34a expression in human breast cancer is associated with drug resistance

ZH Li, X Weng, QY Xiong, JH Tu, A Xiao, W Qiu… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Abstract miR-34a is significantly down-regulated in breast cancer tissues and cell lines,
which may be correlated with breast cancer multi-drug resistance (MDR). Here, we …

MicroRNAs, a promising target for breast cancer stem cells

PK Das, MA Siddika, SY Asha, S Aktar… - Molecular Diagnosis & …, 2020 - Springer
Reactivation of the stem cell programme in breast cancer is significantly associated with
persistent cancer progression and therapeutic failure. Breast cancer stem cells (BCSCs) are …

Concomitant inhibition of cytoprotective autophagy augments the efficacy of withaferin A in hepatocellular carcinoma

S Siddharth, N Muniraj, NK Saxena, D Sharma - Cancers, 2019 - mdpi.com
Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related mortality,
and despite recent advances in early diagnosis and therapeutics, HCC related morbidity …

Concomitant activation of GLI1 and Notch1 contributes to racial disparity of human triple negative breast cancer progression

S Siddharth, S Parida, N Muniraj, S Hercules, D Lim… - Elife, 2021 - elifesciences.org
Mortality from triple negative breast cancer (TNBC) is significantly higher in African American
(AA) women compared to White American (WA) women emphasizing ethnicity as a major …